stockportfolio.pro
TransMedics Group, Inc. Gross Profit 2018–2025
TransMedics Group, Inc. (TMDX) annual gross profit by fiscal year, computed from SEC filings. Compound growth +80.8%/yr over 7 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $362.81M | 59.9% | +38.4% |
| FY 2024 | $262.08M | 59.4% | +70.1% |
| FY 2023 | $154.09M | 63.8% | +136.1% |
| FY 2022 | $65.27M | 69.8% | +208.5% |
| FY 2021 | $21.16M | 69.9% | +27.2% |
| FY 2020 | $16.64M | 64.9% | +20.0% |
| FY 2019 | $13.86M | 58.7% | +141.8% |
| FY 2018 | $5.73M | 44.1% | — |
Source: TransMedics Group, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for TransMedics Group, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTransMedics Group, Inc. — frequently asked questions
What is TransMedics Group, Inc.'s gross profit?
TransMedics Group, Inc. (TMDX) reported gross profit of $362.81M for fiscal year 2025, per its SEC filings.
How has TransMedics Group, Inc.'s gross profit changed over time?
Between fiscal 2018 and 2025, TMDX's gross profit grew at roughly 80.8% per year (compound annual rate), from $5.73M to $362.81M.
Where does this data come from?
Figures are computed from TransMedics Group, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.